Skip to content

Clinical Safety Guidelines for Managing Distal Shoe Complications

Soft Tissue Complications and Clinical Decision-Making in Distal Shoe Therapy: A Prospective Clinical Follow-Up Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07410442
Enrollment
50
Registered
2026-02-13
Start date
2026-08-01
Completion date
2029-02-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Loss of Primary Molars, Soft Tissue Inflammation, Space Maintainer

Keywords

primary second molar, distal shoe, soft tissue complications

Brief summary

Distal shoe space maintainers are the standard of care for guiding the eruption of permanent first molars following the premature loss of the primary second molars. Although this therapy represents established clinical practice, prospective evidence regarding soft tissue complications and predictors of treatment outcomes remains limited. This observational study will prospectively collect clinical outcome data during routine treatment visits. The aims of the study are to characterize patterns of complications, evaluate outcomes related to patient adherence, and identify predictors of treatment success. Ultimately, this study seeks to support the development of standardized strategies for clinical monitoring and complication management.

Detailed description

The premature loss of a primary second molar prior to the eruption of the permanent first molar represents a significant clinical challenge in pediatric dentistry. Without appropriate intervention, the unerupted permanent first molar invariably drifts mesially during its eruptive path, resulting in severe arch length deficiency, impaction of the permanent second premolar, and complex malocclusions. The distal shoe space maintainer is the definitive intervention for these cases; its subgingival guide plane acts as a critical buttress, directing the permanent first molar into its correct anatomical position. Despite its status as a standard clinical procedure, standardized clinical monitoring protocols and evidence-based complication management strategies remain limited. Current literature is primarily restricted to case reports and small retrospective series characterized by substantial heterogeneity in appliance design, follow-up intervals, and criteria for clinical success. Consequently, existing data offer descriptive or anecdotal observations rather than robust, prospective evidence. This gap in the literature leaves several critical clinical concerns unresolved: Histological and Soft Tissue Ambiguity: Because the appliance's distal extension penetrates the gingival epithelium, it creates a potential pathway for bacterial ingress. There is a significant dearth of prospective data regarding long-term gingival health, the nature of the epithelial attachment, and the chronic inflammatory response at the subgingival metal interface. Non-Standardized Complication Management: Clinicians currently lack a universal framework or validated assessment tool for managing prevalent complications, such as localized gingival inflammation, ulceration, appliance fracture, or cement failure. Uncertain Predictors of Success: In the absence of systematic longitudinal monitoring, it remains difficult to quantify how patient-specific variables-specifically oral hygiene adherence and individual gingival reactivity-influence overall treatment success and post-operative morbidity. Therefore, this prospective study is essential to systematically investigate soft tissue responses and complication patterns. By documenting these outcomes through standardized follow-up and data collection protocols, this research aims to establish evidence-based clinical guidelines and a decision-making framework to optimize treatment outcomes and minimize patient morbidity.

Interventions

his study involves the prospective observational monitoring of clinical outcomes during standard distal shoe therapy. Research activities consist of systematic documentation of clinical data, including radiographic assessment of the intra-alveolar blade depth measured from the mesial margin of the permanent first molar, standardized gingival health scores, and caregiver-reported compliance. No experimental modifications to the clinical device or surgical procedures are performed, ensuring the study reflects routine clinical practice.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric participants aged 3 to 9 years * American Society of Anesthesiologists (ASA) Physical Status I or II * Clinical indication for distal shoe therapy as the standard of care * Undergoing distal shoe space maintainer placement * Parent or caregiver able to provide consent and comply with follow-up visits

Exclusion criteria

* Presence of systemic medical conditions that may affect bone metabolism or wound healing * Patients unable or unwilling to comply with the planned follow-up schedule (up to 24 months) * Patients with contraindications to distal shoe therapy based on clinical judgment

Design outcomes

Primary

MeasureTime frameDescription
Incidence and severity of soft tissue complications adjacent to the distal shoe applianceFrom appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).Assessment of the proportion of participants experiencing localized soft tissue complications and the graded severity of such responses. Evaluation includes the presence of gingival inflammation, ulceration, granulation tissue formation, or clinical signs of infection. These complications will be systematically documented during standardized clinical examinations at each follow-up visit. Severity will be categorized using a defined clinical scale (none, mild, moderate, severe). For participants with multiple symptoms, the overall severity will be reported based on the most severe clinical finding to arrive at one aggregated value per participant.

Secondary

MeasureTime frameDescription
Frequency of missed follow-up appointments per participantFrom appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).Assessment of patient and caregiver compliance through the systematic tracking of scheduled routine follow-up visits. This measure quantifies the total number of missed appointments during the study period for each participant, reflecting adherence to the prescribed clinical monitoring protocol.
Adherence to oral hygiene instructions based on clinical assessmentFrom appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).Evaluation of patient/caregiver adherence to standardized oral hygiene protocols. Adherence will be assessed during routine follow-up visits and reported as the number of participants who consistently maintain adequate oral hygiene (e.g., meeting predefined clinical criteria for plaque control) throughout the study duration.
Incidence of successful eruption guidance of the permanent first molarFrom appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).The success of eruption guidance will be determined by verifying the correct anatomical positioning of the permanent first molar. Success is defined by radiographic assessment (bitewing radiographs) and standardized clinical photographs showing the molar in its intended position without impaction or significant mesial drifting. Results will be reported as the number of participants achieving successful eruption guidance.

Countries

United States

Contacts

CONTACTMi Sook Lee, DMD, MSD, PhD
misooklee@ufl.edu352-273-7643
CONTACTMarcio Guelmann, DDS
mguelmann@dental.ufl.edu352-273-7635
PRINCIPAL_INVESTIGATORMi Sook Lee, DMD, MSD, PhD

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026